Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Endovascular therapy for erectile dysfunction: insights from more than 1000 treatments.

CVIR endovascular·2026
Same author

Challenging the paradigm: what is vasculogenic erectile dysfunction?

International journal of impotence research·2026
Same author

Volumetric perfusion fraction change in MR angiography for monitoring sclerotherapy-related changes in peripheral venous malformations.

European journal of radiology·2026
Same author

The Society of Thoracic Surgeons 2026 Clinical Practice Guidelines for the Prevention and Treatment of New-Onset Postoperative Atrial Fibrillation After Cardiac Surgery.

The Annals of thoracic surgery·2026
Same author

Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry.

Circulation. Cardiovascular interventions·2026
Same author

Embolization therapy for pelvic arteriovenous malformations: a systematic review.

CVIR endovascular·2026
Same journal

Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders.

Thrombosis and haemostasis·2026
Same journal

The Interaction of Fibrin with Endothelial Cell Receptor N-Cadherin Promotes Fibrin-Dependent Angiogenesis.

Thrombosis and haemostasis·2026
Same journal

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

Thrombosis and haemostasis·2026
Same journal

Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?

Thrombosis and haemostasis·2026
Same journal

Methylglyoxal Promotes RBC-Driven Procoagulant Activity and Venous Thrombosis under Diabetes-Relevant Conditions.

Thrombosis and haemostasis·2026
Same journal

Management of Inferior Vena Cava Thrombosis: Guidance from the Italian Society for the Study of Haemostasis and Thrombosis.

Thrombosis and haemostasis·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

Cell-based therapy facilitates venous thrombus resolution.

Stefano Di Santo1, Oren M Tepper, Moritz Wyler von Ballmoos

  • 1Division of Vascular Medicine, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Freiburgstrasse, CH-3010 Bern, Switzerland.

Thrombosis and Haemostasis
|March 12, 2009
PubMed
Summary
This summary is machine-generated.

Therapeutic administration of endothelial progenitor cells (EPC) significantly enhances venous thrombus resolution by promoting neovascularization and increasing blood flow. This suggests EPC transplantation could be a valuable treatment for venous thrombosis. Keywords: endothelial progenitor cells, venous thrombus resolution, neovascularization, blood flow.

More Related Videos

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis
06:03

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis

Published on: July 12, 2011

Rodent Inferior Vena Cava Venoplasty Balloon Model
05:44

Rodent Inferior Vena Cava Venoplasty Balloon Model

Published on: May 24, 2024

Related Experiment Videos

Last Updated: Jun 24, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis
06:03

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis

Published on: July 12, 2011

Rodent Inferior Vena Cava Venoplasty Balloon Model
05:44

Rodent Inferior Vena Cava Venoplasty Balloon Model

Published on: May 24, 2024

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Vascular Biology

Background:

  • Endothelial progenitor cells (EPCs) play a role in cardiovascular healing and are found in resolving venous thrombi.
  • Current therapies for venous thrombosis have limitations, necessitating novel treatment strategies.

Purpose of the Study:

  • To investigate the therapeutic potential of EPC administration in enhancing venous thrombus resolution.
  • To assess the impact of EPCs on thrombus organization, neovascularization, and blood flow.

Main Methods:

  • Venous thrombosis induced in the infrarenal inferior vena cava (IVC) of 28 athymic nude rats.
  • Culture-expanded human EPCs injected intravenously 2 and 4 days post-thrombus induction.
  • Assessed recanalisation via laser Doppler blood flow measurements and immunohistochemistry for endothelialization.

Main Results:

  • EPC transplantation significantly increased thrombus neovascularization (capillary density and area covered by capillaries).
  • Substantial increase in intra-thrombus blood flow (perfusion ratio) observed in EPC-treated rats.
  • Augmented macrophage recruitment into resolving thrombi in animals treated with EPCs.

Conclusions:

  • EPC transplantation effectively promotes venous thrombus resolution.
  • Enhanced neovascularization and blood flow are key mechanisms of EPC action.
  • EPC therapy shows potential clinical value for treating venous thrombosis, especially when conventional methods are insufficient.